Role of the low-affinity leukotriene B 4 receptor BLT2 in VEGF-induced angiogenesis

Geun Young Kim, Jin Wook Lee, Sung Hoon Cho, Ji Min Seo, Jae-Hong Kim

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

OBJECTIVE-: The leukotriene B4 (LTB4) receptor BLT2 is expressed in endothelium, but no clear physiological function for it has yet been identified, especially in vascular angiogenesis. The purpose of this study is to characterize the potential function of BLT2 in vascular endothelial growth factor (VEGF)-induced angiogenesis. METHODS AND RESULTS-: VEGF significantly upregulates BLT2 expression in human umbilical vein endothelial cells (HUVECs), and BLT2 knockdown by siRNA or inhibition of BLT2 by a specific BLT2 antagonist LY255283 attenuates VEGF-induced angiogenesis, which was determined by its effect on the formation of tube-like structures and on transmigration. The role of BLT2 in VEGF-induced angiogenesis was more evident in vivo, where BLT2 inhibition by LY255283 almost completely blocked VEGF-induced vessel formation in Matrigel-plug assays. In addition, we found that VEGF upregulates synthesis of the BLT2 ligand, 12(S)-hydroxyeicosatetraenoic acid (HETE). siRNA knockdown of 12-lipoxygenase (12-LO) expression attenuates VEGF-induced angiogenesis in HUVECs, and the addition of 12(S)-HETE to the 12-LO knockdown-HUVECs restores VEGF-induced angiogenesis. The activation of BLT2 itself by either 12(S)-HETE or LTB4 evoked significant angiogenic phenotypes, both in vitro and in vivo. CONCLUSION-: Our findings indicate that BLT2 plays an essential role in mediating VEGF-induced angiogenesis.

Original languageEnglish
Pages (from-to)915-920
Number of pages6
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume29
Issue number6
DOIs
Publication statusPublished - 2009 Jun 1

Fingerprint

Leukotriene B4
Vascular Endothelial Growth Factor A
12-Hydroxy-5,8,10,14-eicosatetraenoic Acid
LY 255283
Human Umbilical Vein Endothelial Cells
Arachidonate 12-Lipoxygenase
Small Interfering RNA
Up-Regulation
Leukotriene B4 Receptors
Endothelium
Blood Vessels
Ligands
Phenotype

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Role of the low-affinity leukotriene B 4 receptor BLT2 in VEGF-induced angiogenesis. / Kim, Geun Young; Lee, Jin Wook; Cho, Sung Hoon; Seo, Ji Min; Kim, Jae-Hong.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 29, No. 6, 01.06.2009, p. 915-920.

Research output: Contribution to journalArticle

Kim, Geun Young ; Lee, Jin Wook ; Cho, Sung Hoon ; Seo, Ji Min ; Kim, Jae-Hong. / Role of the low-affinity leukotriene B 4 receptor BLT2 in VEGF-induced angiogenesis. In: Arteriosclerosis, Thrombosis, and Vascular Biology. 2009 ; Vol. 29, No. 6. pp. 915-920.
@article{21f0548296ca43b9918812bb721d0217,
title = "Role of the low-affinity leukotriene B 4 receptor BLT2 in VEGF-induced angiogenesis",
abstract = "OBJECTIVE-: The leukotriene B4 (LTB4) receptor BLT2 is expressed in endothelium, but no clear physiological function for it has yet been identified, especially in vascular angiogenesis. The purpose of this study is to characterize the potential function of BLT2 in vascular endothelial growth factor (VEGF)-induced angiogenesis. METHODS AND RESULTS-: VEGF significantly upregulates BLT2 expression in human umbilical vein endothelial cells (HUVECs), and BLT2 knockdown by siRNA or inhibition of BLT2 by a specific BLT2 antagonist LY255283 attenuates VEGF-induced angiogenesis, which was determined by its effect on the formation of tube-like structures and on transmigration. The role of BLT2 in VEGF-induced angiogenesis was more evident in vivo, where BLT2 inhibition by LY255283 almost completely blocked VEGF-induced vessel formation in Matrigel-plug assays. In addition, we found that VEGF upregulates synthesis of the BLT2 ligand, 12(S)-hydroxyeicosatetraenoic acid (HETE). siRNA knockdown of 12-lipoxygenase (12-LO) expression attenuates VEGF-induced angiogenesis in HUVECs, and the addition of 12(S)-HETE to the 12-LO knockdown-HUVECs restores VEGF-induced angiogenesis. The activation of BLT2 itself by either 12(S)-HETE or LTB4 evoked significant angiogenic phenotypes, both in vitro and in vivo. CONCLUSION-: Our findings indicate that BLT2 plays an essential role in mediating VEGF-induced angiogenesis.",
author = "Kim, {Geun Young} and Lee, {Jin Wook} and Cho, {Sung Hoon} and Seo, {Ji Min} and Jae-Hong Kim",
year = "2009",
month = "6",
day = "1",
doi = "10.1161/ATVBAHA.109.185793",
language = "English",
volume = "29",
pages = "915--920",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Role of the low-affinity leukotriene B 4 receptor BLT2 in VEGF-induced angiogenesis

AU - Kim, Geun Young

AU - Lee, Jin Wook

AU - Cho, Sung Hoon

AU - Seo, Ji Min

AU - Kim, Jae-Hong

PY - 2009/6/1

Y1 - 2009/6/1

N2 - OBJECTIVE-: The leukotriene B4 (LTB4) receptor BLT2 is expressed in endothelium, but no clear physiological function for it has yet been identified, especially in vascular angiogenesis. The purpose of this study is to characterize the potential function of BLT2 in vascular endothelial growth factor (VEGF)-induced angiogenesis. METHODS AND RESULTS-: VEGF significantly upregulates BLT2 expression in human umbilical vein endothelial cells (HUVECs), and BLT2 knockdown by siRNA or inhibition of BLT2 by a specific BLT2 antagonist LY255283 attenuates VEGF-induced angiogenesis, which was determined by its effect on the formation of tube-like structures and on transmigration. The role of BLT2 in VEGF-induced angiogenesis was more evident in vivo, where BLT2 inhibition by LY255283 almost completely blocked VEGF-induced vessel formation in Matrigel-plug assays. In addition, we found that VEGF upregulates synthesis of the BLT2 ligand, 12(S)-hydroxyeicosatetraenoic acid (HETE). siRNA knockdown of 12-lipoxygenase (12-LO) expression attenuates VEGF-induced angiogenesis in HUVECs, and the addition of 12(S)-HETE to the 12-LO knockdown-HUVECs restores VEGF-induced angiogenesis. The activation of BLT2 itself by either 12(S)-HETE or LTB4 evoked significant angiogenic phenotypes, both in vitro and in vivo. CONCLUSION-: Our findings indicate that BLT2 plays an essential role in mediating VEGF-induced angiogenesis.

AB - OBJECTIVE-: The leukotriene B4 (LTB4) receptor BLT2 is expressed in endothelium, but no clear physiological function for it has yet been identified, especially in vascular angiogenesis. The purpose of this study is to characterize the potential function of BLT2 in vascular endothelial growth factor (VEGF)-induced angiogenesis. METHODS AND RESULTS-: VEGF significantly upregulates BLT2 expression in human umbilical vein endothelial cells (HUVECs), and BLT2 knockdown by siRNA or inhibition of BLT2 by a specific BLT2 antagonist LY255283 attenuates VEGF-induced angiogenesis, which was determined by its effect on the formation of tube-like structures and on transmigration. The role of BLT2 in VEGF-induced angiogenesis was more evident in vivo, where BLT2 inhibition by LY255283 almost completely blocked VEGF-induced vessel formation in Matrigel-plug assays. In addition, we found that VEGF upregulates synthesis of the BLT2 ligand, 12(S)-hydroxyeicosatetraenoic acid (HETE). siRNA knockdown of 12-lipoxygenase (12-LO) expression attenuates VEGF-induced angiogenesis in HUVECs, and the addition of 12(S)-HETE to the 12-LO knockdown-HUVECs restores VEGF-induced angiogenesis. The activation of BLT2 itself by either 12(S)-HETE or LTB4 evoked significant angiogenic phenotypes, both in vitro and in vivo. CONCLUSION-: Our findings indicate that BLT2 plays an essential role in mediating VEGF-induced angiogenesis.

UR - http://www.scopus.com/inward/record.url?scp=66349135079&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66349135079&partnerID=8YFLogxK

U2 - 10.1161/ATVBAHA.109.185793

DO - 10.1161/ATVBAHA.109.185793

M3 - Article

C2 - 19286633

AN - SCOPUS:66349135079

VL - 29

SP - 915

EP - 920

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 6

ER -